Spinocerebellar ataxia type 6 (SCA6) is due to small expansions of a CAG re
peat at the 3' end of the CACNA1A gene, coding for the alpha (1A) subunit o
f voltage-gated calcium channels type P/Q, expressed in the cerebellar Purk
inje and granule cells. it is one of three allelic disorders, the other two
being episodic ataxia type 2 (EA2), due mostly to protein truncating mutat
ions, and familial hemiplegic migraine, associated with missense mutations.
The latter disorders, due to point mutations altering the P/Q channel acti
vity, clearly belong to the group of channelopathies. For SCA6, due to CAGn
expansions, a toxic gain of function might, instead, be envisaged homologo
us to that of glutamine repeat disorders. A comparison between SCA6 and EA2
phenotypes performed on available literature data, shows that the clinical
features of the two disorders are widely overlapping and that the differen
ces could be accounted for with the older age of patients in the SCA6 group
. A similar phenotype in the two disorders could imply the same pathogenic
process. Functional analyses on cells expressing the protein with an expand
ed polyglutamine stretch have shown, in fact, an altered channel activity.
In conclusion, available data seem to suggest that SCA6 is more likely belo
nging to channelopathies than to polyglutamine disorders. (C) 2001 Elsevier
Science Inc.